New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed...

Related Keywords

Switzerland ,United States ,Japan ,American ,America ,Birgit Masjost ,Robert Wood ,Rebekka Schnell ,Nathalie Altermatt ,Bruno Eschli ,Levi Garraway ,Sabine Borngr ,Kirti Pandey ,Simon Goldsborough ,R Sharon Chinthrajah ,Karsten Kleine ,Loren Kalm ,Sileia Urech ,Head Of Global Product Development ,Johns Hopkins Children Center ,Genentech Inc ,Drug Administration ,Novartis Pharmaceuticals Corporation ,Consortium For Food Allergy Research Co ,National Institute Of Allergy ,Public Health Impact Of Parent ,Asthma Research ,Roche Group ,Inspection Service ,Eudowood Division Of Allergy ,American Academy Of Allergy ,Genentech ,National Institutes Of Health ,Stanford School Of Medicine ,Seann Parker Center ,National Institutes ,New England Journal ,Eudowood Division ,Johns Hopkins Children ,Stanford School ,Secondary Endpoints Results ,Paediatric Population ,Key Secondary ,Additional Secondary ,Chief Medical Officer ,Global Product ,Adjunct Therapy ,Food Allergic Children ,National Institute ,Infectious Diseases ,Food Allergy Research ,Novartis Pharmaceuticals ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Food Allergies Among ,Public Health Impact ,Parent Reported Childhood Food Allergies ,Accessed November ,Food Equivalents ,Food Allergy ,Environmental Factors ,Accessed February ,